Nautilus Biotechnology, Inc. (NAUT)
Nautilus Biotechnology Market Cap : 286.26M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 286.26M |
| October 08, 2026 | 231.55M |
| October 07, 2026 | 249.36M |
| October 06, 2026 | 225.19M |
| October 05, 2026 | 237.91M |
| October 02, 2026 | 249.36M |
| October 01, 2026 | 199.74M |
| September 30, 2026 | 180.66M |
| September 29, 2026 | 173.66M |
| September 28, 2026 | 141.22M |
| September 25, 2026 | 122.48M |
| September 24, 2026 | 126.02M |
| September 23, 2026 | 121.36M |
| September 22, 2026 | 127.15M |
| September 21, 2026 | 121.46M |
| September 18, 2026 | 122.90M |
| September 17, 2026 | 123.62M |
| September 16, 2026 | 123.68M |
| September 15, 2026 | 113.37M |
| September 14, 2026 | 115.30M |
| September 11, 2026 | 129.77M |
| September 10, 2026 | 125.90M |
| September 09, 2026 | 142.49M |
| September 08, 2026 | 118.05M |
| September 04, 2026 | 115.13M |
| Date | Value |
|---|---|
| September 03, 2026 | 116.98M |
| September 02, 2026 | 122.36M |
| September 01, 2026 | 117.87M |
| August 31, 2026 | 123.71M |
| August 28, 2026 | 112.68M |
| August 27, 2026 | 115.02M |
| August 26, 2026 | 119.26M |
| August 25, 2026 | 112.12M |
| August 24, 2026 | 111.36M |
| August 21, 2026 | 121.44M |
| August 20, 2026 | 114.79M |
| August 19, 2026 | 114.69M |
| August 18, 2026 | 108.37M |
| August 17, 2026 | 112.02M |
| August 14, 2026 | 113.48M |
| August 13, 2026 | 113.23M |
| August 12, 2026 | 114.46M |
| August 11, 2026 | 113.33M |
| August 10, 2026 | 110.05M |
| August 07, 2026 | 114.51M |
| August 06, 2026 | 112.73M |
| August 05, 2026 | 118.32M |
| August 04, 2026 | 125.35M |
| August 03, 2026 | 128.50M |
| July 31, 2026 | 124.30M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Agilent Technologies, Inc. | 48.09B |
| Bio-Rad Laboratories, Inc. | 9.790B |
| Bruker Corp. | 8.964B |
| Danaher Corp. | 154.50B |
| Harvard Bioscience, Inc. | 37.51M |
Market Cap Related Metrics
| PS Ratio | 1499.34 |
| Price to Book Value | 2.183 |
| Price | 2.25 |
| Earnings Yield | -19.84% |